APA (7th ed.) Citation

Langley, B. O., Ryan, J. J., Phipps, J., Buttolph, L., Bray, B., Aslan, J. E., . . . Bradley, R. (2022). Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): A protocol for a phase II triple-masked, placebo-controlled clinical trial. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06782-z

Chicago Style (17th ed.) Citation

Langley, Blake O., Jennifer Joan Ryan, John Phipps, Lita Buttolph, Brenna Bray, Joseph E. Aslan, Thomas O. Metz, Jan F. Stevens, and Ryan Bradley. "Xanthohumol Microbiome and Signature in Adults with Crohn's Disease (the XMaS Trial): A Protocol for a Phase II Triple-masked, Placebo-controlled Clinical Trial." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06782-z.

MLA (9th ed.) Citation

Langley, Blake O., et al. "Xanthohumol Microbiome and Signature in Adults with Crohn's Disease (the XMaS Trial): A Protocol for a Phase II Triple-masked, Placebo-controlled Clinical Trial." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06782-z.